The intestinal peristaltic reflex can be elicited by mucosal stimulation or circular muscle stretch. Muscle stretch activates extrinsic, whereas mucosal stimulation activates intrinsic calcitonin gene-related peptide (CGRP)-containing sensory neurons. The present study examined the role of 5-hydroxytryptamine (5-HT) in sensory transmission. A three-compartment preparation of rat colon was used that enables separate measurement of sensory transmitters and modulators. Mucosal stimuli (2-8 brush strokes) caused concurrent increase in 5-HT and CGRP release in proportion to the intensity of stimulation. Release of both 5-HT and CGRP occurred exclusively into the central compartment where the stimuli were applied. Exogenous 5-HT caused a concentration-dependent release of CGRP. Release of CGRP induced by exogenous 5-HT or mucosal stimulation was inhibited by selective 5-HT4 and 5-HT1p antagonists but was not affected by 5-HT1A, 5-HT2, and 5-HT3 antagonists. Ascending contraction and descending relaxation of circular muscle measured in the peripheral orad and caudad compartments, respectively, were also selectively inhibited by 5-HT4 and 5-HT1p antagonists added to the central but not peripheral compartments. In contrast, muscle stretch elicited CGRP but not 5-HT release; the ascending contraction and descending relaxation components of the peristaltic reflex induced by muscle stretch were not affected by 5-HT antagonists. We conclude that 5-HT released by mucosal stimulation initiates the peristaltic reflex by activating 5-HT4/5-HT1p receptors on sensory CGRP-containing neurons.
The aim of this study was to identify the nitric oxide synthase (NOS) isoform expressed in freshly dispersed rabbit gastric smooth muscle cells and in cultured rabbit gastric, human intestinal, and guinea pig taenia coli smooth muscle cells. RT-PCR products of the predicted size (354 bp) were obtained with endothelial NOS (eNOS)-specific primers, but not neuronal NOS (nNOS)- or inducible NOS (iNOS)-specific primers, in all smooth muscle preparations except guinea pig taenia coli. Control RT-PCR studies showed absence of the endothelial markers, platelet endothelial cell adhesion molecule-1 (PECAM-1) and vascular endothelial growth factor receptor (VEGFR), and the interstitial cell marker, c- kit, from cultures of smooth muscle cells. Cloning and sequence analysis showed that the predicted amino acid sequence (117 residues) in rabbit and human smooth muscle cells differed by only one residue from that of human eNOS. Northern blot analysis, using the PCR-generated and cloned eNOS cDNA from rabbits and humans as probes, demonstrated the expression of eNOS mRNA (4.4 kb) in both species. eNOS, but not nNOS or iNOS, transcripts were localized by in situ RT-PCR in single, freshly dispersed rabbit gastric smooth muscle cells; expression was evident in the majority of cells in each preparation. We conclude that eNOS is selectively expressed in rabbit gastric and human intestinal smooth muscle cells. The results confirm functional evidence for the existence of a constitutive NOS in smooth muscle cells of the gut in different species, except for guinea pig taenia coli.
Background & Aims
The inflammatory bowel diseases (IBD) ulcerative colitis (UC) and
Crohn’s disease (CD) cause significant morbidity and are increasing in
prevalence among all populations, including African Americans. More than 200
susceptibility loci have been identified in populations of predominantly European
ancestry, but few loci have been associated with IBD in other ethnicities.
Methods
We performed 2 high-density, genome-wide scans comprising 2345 cases of African
Americans with IBD (1646 with CD, 583 with UC, and 116 inflammatory bowel disease
unclassified [IBD-U]) and 5002 individuals without IBD (controls,
identified from the Health Retirement Study and Kaiser Permanente database).
Single-nucleotide polymorphisms (SNPs) associated at P<5.0×10−8 in
meta-analysis with a nominal evidence (P<.05) in each scan were considered to have
genome-wide significance.
Results
We detected SNPs at HLA-DRB1, and African-specific SNPs at ZNF649 and LSAMP,
with associations of genome-wide significance for UC. We detected SNPs at USP25 with
associations of genome-wide significance associations for IBD. No associations of
genome-wide significance were detected for CD. In addition, 9 genes previously
associated with IBD contained SNPs with significant evidence for replication
(P<1.6×10−6): ADCY3, CXCR6, HLA-DRB1 to HLA-DQA1 (genome-wide
significance on conditioning), IL12B, PTGER4, and TNC for IBD; IL23R, PTGER4, and SNX20
(in strong linkage disequilibrium with NOD2) for CD; and KCNQ2 (near TNFRSF6B) for UC.
Several of these genes, such as TNC (near TNFSF15), CXCR6, and genes associated with IBD
at the HLA locus, contained SNPs with unique association patterns with African-specific
alleles.
Conclusions
We performed a genome-wide association study of African Americans with IBD and
identified loci associated with CD and UC in only this population; we also replicated
loci identified in European populations. The detection of variants associated with IBD
risk in only people of African descent demonstrates the importance of studying the
genetics of IBD and other complex diseases in populations beyond those of European
ancestry.
Crohn’s disease is complicated by the development of fibrosis and stricture in ~30–50% of patients over time. The pathogenesis of fibrostenotic disease is multifactorial involving the activation of mesenchymal cells by cytokines, growth factors and other mediators released by immune cells, epithelial cells and mesenchymal cells themselves. Transforming growth factor-β (TGF-β), a key activator of mesenchymal cells, is central to the process of fibrosis and regulates numerous genes involved in the disordered wound healing including collagens, and other extracellular matrix proteins, connective tissue growth factor (CTGF), and insulin-like growth factors (IGFs). The activated mesenchymal compartment is expanded by recruitment of new mesenchymal cells via epithelial to mesenchymal transition, endothelial to mesenchymal transition and invasion of circulating fibrocytes. Cellular hyperplasia and increased extracellular matrix (ECM) production, particularly collagens, from fibroblasts, myofibroblasts and smooth muscle cells add to the disturbed architecture and scarring on the intestine. ECM homeostasis is further disrupted by alterations in the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs) in the gut. Among the 163 susceptibility genes identified that contribute to susceptibility in IBD mutations in NOD2/CARD15, innate immune system components, and autophagy jointly contribute to the activation of mesenchymal cells and pathogenesis of fibrosis in this polygenic disorder. Numerous growth factorscytokinesand other mediators. The review focuses on the molecular mechanism that regulate mesenchymal cell function, particularly smooth muscle cells, the largest compartment of mesenchyme in the intestine, that lead to fibrosis in Crohn’s disease.
Insulin-like growth factor I (IGF-I), acting via its cognate receptor, plays an autocrine role in the regulation of growth of intestinal muscle cells. In the present study the signaling pathways mediating the growth effects of IGF-I were characterized in cultured human intestinal smooth muscle cells. Growth induced by a maximally effective concentration of IGF-I (100 nM), measured as [3H]thymidine incorporation, was only partially inhibited by LY-294002 [phosphatidylinositol 3-kinase (PI 3-kinase) inhibitor] or PD-98059 [mitogen-activated protein (MAP) kinase kinase (MEK) inhibitor] (86 ± 7% and 35 ± 6% inhibition, respectively) alone but was abolished by the two combined (114 ± 18% inhibition), implying the participation of both pathways. IGF-I elicited time- and concentration-dependent increases in PI 3-kinase activity. This effect was inhibited only by LY-294002 (89 ± 12%). IGF-I elicited time- and concentration-dependent phosphorylation of p44/p42 MAP kinase and increased MAP kinase activity. These effects were inhibited only by PD-98059 (78 ± 9% and 98 ± 7%, respectively). We conclude that in human intestinal muscle cells IGF-I activates distinct PI 3-kinase and MAP kinase signaling pathways, which act in conjunction to mediate growth.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.